Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patients.
Verena ScheperMelanie SchmidtheislerFlorian LaschHeiko von der LeyenArmin KochJana SchwiegerAndreas BüchnerAnke Lesinski-SchiedatThomas LenarzPublished in: Trials (2020)
European Commission FP7-HEALTH-2012-INNOVATION-2.
Keyphrases
- double blind
- placebo controlled
- clinical trial
- end stage renal disease
- phase ii
- phase iii
- open label
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- public health
- study protocol
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- radiation therapy
- climate change
- social media
- human health
- health promotion